Journal of Peking University (Health Sciences) ›› 2024, Vol. 56 ›› Issue (5): 923-927. doi: 10.19723/j.issn.1671-167X.2024.05.027

Previous Articles     Next Articles

Fulminant type 1 diabetes mellitus with acute pancreatitis: A case report and literature review

Peiheng ZHANG, Ying GAO, Honghua WU, Jian ZHANG*(), Junqing ZHANG   

  1. Department of Endocrinology, Peking University First Hospital, Beijing 100034, China
  • Received:2021-07-30 Online:2024-10-18 Published:2024-10-16
  • Contact: Jian ZHANG E-mail:zhangjian8971@163.com

RICH HTML

  

Abstract:

The objective was to report a relatively rare case of fulminant type 1 diabetes (FT1DM) complicated with acute pancreatitis (AP), to summarize the characteristics as well as experience of diagnosis and treatment, and to explore its pathogenesis. Clinical data of a case of FT1DM complicated with AP in the Department of Endocrinology of our hospital were analyzed retrospectively. A 66-year-old male presented with acute fever and abdominal pain, accompanying with the significantly elevated pancreatic enzymes, and his abdominal CT scan showed exudation around the pancreas. The clinical manifestations mentioned above were consistent with the diagnosis of AP. Five days after onset, the patient developed clinical symptoms, such as obvious thirst, polyuria, polyasthenia and fatigue. Meanwhile, his plasma glucose increased significantly and the diabetic ketoacidosis (DKA) occurred. The patient's fasting and postprandial 2 hours C peptide decreased significantly (all 0.02 μg/L), glycated hemoglobin level was not high (6%), and his islet-related autoantibodies were undetectable. Thus, the patient could be diagnosed with FT1DM. After the treatment of fasting, fluid replacement, anti-infection, somatostatin, anticoagulation and intravenous insulin sequential subcutaneous insulin pump, the patient gained the alleviation of pancreatitis, restoration of oral intake, and relatively stable blood glucose levels. Summarizing the characte-ristics of this case and reviewing the literature, FT1DM complicated with AP was relatively rare in FT1DM. Its common characteristics were described below: (1) Most cases started with AP and the blood glucose elevated within 1 week, or some cases had the simultaneously onset of AP and FT1DM. (2) The clinical course of AP was short and relieved no more than 1 week; Pancreatic imaging could completely return to normal within 1 to 4 weeks after onset. (3) The etiology of AP most was idiopathic; The elevation of pancreatic enzyme level was slight and the recovery was rapidly compared with AP of other etiologies. FT1DM could be complicated with AP, which was different from the physiological manifestations of pancreatic disease in general FT1DM patients. Virus infection mignt be the common cause of AP and FT1DM, and AP might be the early clinical manifestation of some FT1DM. The FT1DM patients developed with abdominal pain was easy to be missed, misdiagnosed and delayed, which should receive more attention in clinic.

Key words: Diabetes mellitus, type 1, Pancreatitis, Acute disease

CLC Number: 

  • R587.1

Figure 1

Abdominal CT scan at admission (2020-12-19) of the patient with FT1DM complicated with AP Abbreviations as in Table 1."

Table 1

Development of pancreatic exocrine and endocrine laboratory examination of the patient with FT1DM complicated with AP"

Items Date
2020-12-19 2020-12-20 2020-12-22 2021-01-05
FBG/(mmol/L) 5.2 5.6 19.7 6.2
C-peptide/(μg/L) ND ND < 0.01* 0.02*#
Amylase/(IU/L) 427 99 18 16
Lipase/(IU/L) >300 168 9 15
Fat drop or muscle fibers in stool ND ND ND ND

Figure 2

Abdominal CT scan after symptom relief (2021-01-08) of the patient with FT1DM complicated with AP"

1 Imagawa A , Hanafusa T , Miyagawa JI , et al. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group[J]. N Engl J Med, 2000, 342 (5): 301- 307.
doi: 10.1056/NEJM200002033420501
2 柳岚, 曾玲, 桑丹, 等. 暴发性1型糖尿病研究新进展[J]. 中国糖尿病杂志, 2018, 26 (5): 431- 436.
3 Luo S , Zhang Z , Li X , et al. Fulminant type 1 diabetes: A collaborative clinical cases investigation in China[J]. Acta Diabetol, 2013, 50 (1): 53- 59.
doi: 10.1007/s00592-011-0362-1
4 李照青, 张金苹. 暴发性1型糖尿病患者的患病情况及临床特征[J]. 中华内科杂志, 2016, 55 (11): 849- 853.
5 郑超, 林健, 杨琳, 等. 暴发性1型糖尿病的患病状况及其特征[J]. 中华内分泌代谢杂志, 2010, 26 (3): 188- 191.
6 Imagawa A , Hanafusa T , Awata T , et al. Report of the Committee of the Japan Diabetes Society on the research of fulminant and acute-onset type 1 diabetes mellitus: New diagnostic criteria of fulminant type 1 diabetes mellitus (2012)[J]. J Diabetes Investig, 2012, 3 (6): 536- 539.
doi: 10.1111/jdi.12024
7 Sakurai K , Niitsuma S , Sato R , et al. Painless thyroiditis and fulminant type 1 diabetes mellitus in a patient treated with an immune checkpoint inhibitor, nivolumab[J]. Tohoku J Exp Med, 2018, 244 (1): 33- 40.
doi: 10.1620/tjem.244.33
8 Imagawa A . Two types of fulminant type 1 diabetes mellitus: Immune checkpoint inhibitor-related and conventional[J]. J Diabetes Investig, 2021, 12 (6): 917- 919.
doi: 10.1111/jdi.13450
9 Kyriacou A , Melson E , Chen W , et al. Is immune checkpoint inhibitor-associated diabetes the same as fulminant type 1 diabetes mellitus?[J]. Clin Med (Lond), 2020, 20 (4): 417- 423.
10 中华医学会急诊分会, 京津冀急诊急救联盟, 北京医学会急诊分会, 等. 急性胰腺炎急诊诊断及治疗专家共识[J]. 中华急诊医学杂志, 2021, 30 (2): 161- 172.
11 Rawla P , Bandaru SS , Vellipuram AR . Review of infectious etiology of acute pancreatitis[J]. Gastroenterology Res, 2017, 10 (3): 153- 158.
12 Chatila T , Bilal M , Guturu P . Evaluation and management of acute pancreatitis[J]. World J Clin Cases, 2019, 7 (9): 1006- 1020.
13 Yoneda S , Imagawa A , Fukui K , et al. A histological study of fulminant type 1 diabetes mellitus related to human cytomegalovirus reactivation[J]. J Clin Endocrinol Metab, 2017, 102 (7): 2394- 2400.
14 Luo S , Ma X , Li X , et al. Fulminant type 1 diabetes: A comprehensive review of an autoimmune condition[J]. Diabetes Metab Res Rev, 2020, 36 (6): e3317.
15 Imagawa A , Hanafusa T , Miyagawa J , et al. A proposal of three distinct subtypes of type 1 diabetes mellitus based on clinical and pathological evidence[J]. Ann Med, 2000, 32 (8): 539- 543.
16 Obata A , Kaneto H , Kamei S , et al. Pancreatic inflammation captured by imaging technology at the onset of fulminant type 1 diabetes[J]. Diabetes Care, 2015, 38 (9): e135- e136.
17 Nakajima M , Shirokawa M , Nakano T , et al. Fulminant type 1 diabetes mellitus with remarkable elevation of serum pancreatic enzymes[J]. Am J Emerg Med, 2018, 36 (7): e1323- e1326.
18 Yabe D , Kuroe A , Ohya M , et al. A case of fulminant type 1 diabetes mellitus with exocrine pancreatic insufficiency and enhanced glucagon response to meal ingestion[J]. Diabetes Res Clin Pract, 2008, 82 (2): e1- e4.
19 Chen Y , Zhao M , Cui J , et al. Acute pancreatitis may be a pathogenic factor of fulminant type 1 diabetes mellitus[J]. Chin Med J (Engl), 2020, 134 (9): 1127- 1128.
20 Imagawa A , Hanafusa T . Fulminant type 1 diabetes-an important subtype in East Asia[J]. Diabetes Metab Res Rev, 2011, 27 (8): 959- 964.
21 Tanaka S , Aida K , Nishida Y , et al. Pathophysiological mechanisms involving aggressive islet cell destruction in fulminant type 1 diabetes[J]. Endocr J, 2013, 60 (7): 837- 845.
22 陈文俊, 叶文慧, 麦华超. 以急腹症起病的暴发性1型糖尿病一例[J]. 临床内科杂志, 2021, 38 (4): 277- 278.
[1] ZHUANG Jin-man,LI Tian-run,LI Xuan,LUAN Jing-yuan,WANG Chang-ming,FENG Qi-chen,HAN Jin-tao. Application of Rotarex mechanical thrombectomy system in acute lower limb ische-mia [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1159-1162.
[2] LI Hong-liang, JIANG Yuan-hui, WEI Yuan, ZHAO Yang-yu, ZHU Xi, YAO Gai-qi. Clinical analysis of acute hyperlipidemic pancreatitis during pregnancy and postpartum period [J]. Journal of Peking University(Health Sciences), 2014, 46(1): 125-129.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!